REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2023 • Propanc Biopharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 15th, 2023 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”), dated as of November 3, 2022, by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and Coventry Enterprises, LLC, a Delaware limited liability company (together with it permitted assigns, the “Investor”) (the Company and Investor each a “Party” and together the “Parties”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Common Stock Purchase Agreement by and between the Parties, dated as of the date hereof (as amended, restated, supplemented, or otherwise modified from time to time, the “Purchase Agreement”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 18th, 2023
Contract Type FiledApril 18th, 2023THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 25, 2019 (the “Execution Date”), is entered into by and between PROPANC BIOPHARMA, INC., a Delaware corporation (the “Company”), and OASIS CAPITAL, LLC, a Puerto Rico limited liability company (together with its permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in that certain Equity Purchase Agreement by and between the parties hereto, dated as of the Execution Date (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).